Helix Immuno-Oncology Overview

  • Founded
  • 2013
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 4

Helix Immuno-Oncology General Information

Contact Information

Formerly Known As
Helix Polska
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Other Healthcare Technology Systems
Parent Company
CAIAC Fund Management
Primary Office
  • Gen. Sylwestra Kaliski 2
  • Warsaw, 01-476
  • Poland
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Helix Immuno-Oncology Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Helix Immuno-Oncology‘s full profile, request access.

Request a free trial

Helix Immuno-Oncology Executive Team (4)

Name Title Board Seat Contact Info
Pawel Wisniewski Ph.D Executive Vice President & Chief Executive Officer
Anna Bujak Chief Researcher & Principal Investigator
To view Helix Immuno-Oncology’s complete executive team members history, request access »

Helix Immuno-Oncology Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Helix Immuno-Oncology‘s full profile, request access.

Request a free trial